Selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α
, but not HIF-2α
, with HIF-1β
= 1.3 μ
M). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro
. Also reduces tubularization of hypoxic HUVECs.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells.
Miranda E, Nordgren IK, Male AL et al.
J Am Chem Soc